AVBP Operating Expenses

Arrivent Biopharma Inc · Operating Expenses

AVBP logo

AVBP Operating Expenses

Latest reported$175.94M
AVBP TTM Operating Expenses ($36.91M → $175.94M)
High-resolution chart · PNG

AVBP operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arrivent Biopharma Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
175,941,000
156,873,000
177,534,000
162,416,000
148,332,000
140,406,000
94,308,000
93,721,000
86,205,000
83,092,000
74,590,000
61,914,000
56,966,000
41,730,000
36,906,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.